Novel Nailfold Capillaroscopy: A Proof Of Concept

Overview

In the field of microvascular diagnostics, the most significant diseases are those that silently compromise systemic health by attacking the smallest vessels in the human body. Nailfold capillaroscopy (NFC) has been established since the 1970s as a vital, non-invasive diagnostic tool for monitoring these conditions, yet existing clinical systems often remain high-cost, specialized infrastructure (Smith et al). This study introduces a standalone digital capillaroscopy system designed to bridge the access gap by providing high-fidelity microcirculatory imaging in a portable, automated format. The system’s hardware architecture features a Raspberry Pi 4B for high-speed processing, an Arducam IMX477 high-resolution sensor, and a Nema 17 stepper motor to provide precision Z-axis height adjustment of the microscope. The device is designed for standalone operation, incorporating a dedicated finger-stabilization insert, an integrated light source, and an LCD interface for real-time feedback. The software pipeline implements a custom Computer Vision (OpenCV) algorithm that automates the detection of capillary morphology. By utilizing high-sensitivity contrast enhancement (CLAHE) and specialized segmentation algorithms for contiguous microvascular structures, the system extracts critical biomarkers such as capillary density, tortuosity, and hemorrhages. An internal calibration ruler allows the algorithm to perform precise micron-level measurements of arterial and venous loop diameters, with all clinical data exportable to CSV format for longitudinal tracking. The clinical utility of this system extends to a broad diagnostic spectrum, encompassing the 23 distinct diseases and conditions identified as detectable via nailfold capillaroscopy (Komai et al.). This includes its primary role in diagnosing rheumatological disorders such as systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. Furthermore, the system provides a means to detect non-rheumatic conditions, including diabetes, Alzheimer’s disease, glaucoma, and peripheral artery disease. By automating the identification of abnormal patterns, such as reduced capillary density, mega-capillaries, or avascular zones, this system serves as a vital screening tool for progressive pathologies (Miyoshi et al.). Ultimately, this project demonstrates that sophisticated microvascular assessment can be decentralized, moving from specialized labs to routine clinical practice to ensure earlier detection of chronic vascular decline.